Skip to content

Investigating the average score of edema and ecchymosis after rhinoplasty with local anesthetic injection of triamcinolone lidocaine adrenaline solution compared to lidocaine adrenaline solution

Evaluation of mean score of edema and ecchymosis after rhinoplasty by injection of local anesthetic with triamcinolone lidocaine adrenaline solution in comparison with lidocaine adrenaline solution.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231030059908N5
Enrollment
100
Registered
2024-10-03
Start date
2024-09-15
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Ecchymosis after rhinoplasty. Condition 2: Edema after rhinoplasty. Ocular laceration and rupture with prolapse or loss of intraocular tissue Localized edema

Interventions

Intervention 1: Intervention First group: Group A: 10 cc of 2% lidocaine combined with 1% adrenaline will receive. Intervention 2: Intervention group: Group B will receive 10 cc of lidocaine combined

Sponsors

Zahedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Men and women aged 18 to 35 who visit Al-Zahra Zahedan Hospital for rhinoplasty

Exclusion criteria

Exclusion criteria: Patients with a history of gastric ulcer. History of Diabetes mellitus Body deformity disorder History of Tuberculosis History of Herpes simplex History of Hypertion Known allergy to Triamcinolone Known allergy to Lidocaine Known allergy to Adrenaline Use of anticoagulant treatment 5 days before the operation Blood and fibrinolytic disorders

Design outcomes

Primary

MeasureTime frame
Based on the observation of a specialist doctor and the grading form of periorbital edema. Timepoint: 3, 5, 7 days after the start of the operation. Method of measurement: The scale described by Gurlek et al.;Edma. Timepoint: 3, 5, 7 days after the start of the operation. Method of measurement: The scale described by Gurlek et al.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGholamali Dashti Khovidaki

Zahedan University of Medical Sciences

drdashti50@yahoo.com+98 54 3329 5715

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026